Sprint Bioscience AB (SPRINT)

Currency in SEK
0.522
+0.002(+0.38%)
Closed·
SPRINT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
SPRINT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.4920.522
52 wk Range
0.3602.250
Key Statistics
Prev. Close
0.52
Open
0.497
Day's Range
0.492-0.522
52 wk Range
0.36-2.25
Volume
30.83K
Average Volume (3m)
213.51K
1-Year Change
-59.78%
Book Value / Share
0.05
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SPRINT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Sprint Bioscience AB Company Profile

Sprint Bioscience AB (publ), a pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden. The company develops VPS34, a drug candidate for the treatment of various types of cancer by using immunotherapies; TREX1, a drug candidate for the treatment of immuno-oncology, radiotherapy and chemotherapy in the treatment of cancer. It also develops PETRA01, a drug candidate for the treatment of cancer. In addition, the company focuses on research of products for the treatment of tumor metabolism and nash. It has a research collaboration with the Experimental Drug Development Centre for expansion of metabolic dysfunction-associated steatohepatitis programme into inflammatory diseases. Sprint Bioscience AB (publ) was incorporated in 2009 and is based in Huddinge, Sweden.

Compare SPRINT to Peers and Sector

Metrics to compare
SPRINT
Peers
Sector
Relationship
P/E Ratio
−2.6x−8.9x−0.5x
PEG Ratio
0.01−0.180.00
Price/Book
15.2x6.2x2.6x
Price / LTM Sales
0.9x39.3x3.2x
Upside (Analyst Target)
283.1%17.2%44.3%
Fair Value Upside
Unlock2.3%6.6%Unlock

Earnings

Latest Release
May 27, 2025
EPS / Forecast
-0.08 / --
Revenue / Forecast
14.33M / --
EPS Revisions
Last 90 days

SPRINT Income Statement

FAQ

What Stock Exchange Does Sprint Bioscience AB Trade On?

Sprint Bioscience AB is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Sprint Bioscience AB?

The stock symbol for Sprint Bioscience AB is "SPRINT."

What Is the Sprint Bioscience AB Market Cap?

As of today, Sprint Bioscience AB market cap is 55.08M.

What Is Sprint Bioscience AB's Earnings Per Share (TTM)?

The Sprint Bioscience AB EPS (TTM) is -0.30.

When Is the Next Sprint Bioscience AB Earnings Date?

Sprint Bioscience AB will release its next earnings report on 26 Aug 2025.

From a Technical Analysis Perspective, Is SPRINT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Sprint Bioscience AB Stock Split?

Sprint Bioscience AB has split 2 times.

How Many Employees Does Sprint Bioscience AB Have?

Sprint Bioscience AB has 38 employees.

What is the current trading status of Sprint Bioscience AB (SPRINT)?

As of 20 Jul 2025, Sprint Bioscience AB (SPRINT) is trading at a price of 0.52, with a previous close of 0.52. The stock has fluctuated within a day range of 0.49 to 0.52, while its 52-week range spans from 0.36 to 2.25.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.